Intelligence · Clinical pipeline
Metabolic & obesity · Phase II
Metabolic & obesity programs at Phase II — ClinicalTrials.gov pipeline intelligence.
Quick answer
Metabolic & obesity Phase II programs: NovaPharmaNews indexes 210 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 13 programs
- IONIS PHARMACEUTICALS 10 programs
- Oramed Pharmaceuticals 10 programs
- Regeneron UK 10 programs
- United Therapeutics Europe 7 programs
- Anaxis Pharma 6 programs
- NovoThirteen 6 programs
- Vertex Pharmaceuticals (Australia) 6 programs
- vTv Therapeutics 6 programs
- Alnylam Netherlands 5 programs
- LEXICON PHARMACEUTICALS 5 programs
- Rhythm Pharmaceuticals Netherlands 5 programs
Pipeline programs
-
VK2809
Viking Therapeutics
NASH - Nonalcoholic Steatohepatitis
1 trial -
VX-264
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes
1 trial -
VX-264 Implant
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes Mellitus
1 trial -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Diabetic Peripheral Neuropathic Pain
1 trial -
VX24-993-103
Vertex Pharmaceuticals (Australia) Pty.
Pain Associated With Diabetic Peripheral Neuropathy
1 trial -
WOE-DE-2023-2
Lacuna Pharma Pty Ltd
Diabetic sensorimotor polyneuropathy (DSPN)
1 trial -
Yogurt smoothie with BB-12
United Therapeutics Europe Ltd
Metabolic Syndrome
1 trial -
Zemplar (paricalcitol ) capsules
Abbott Australasia Pty Ltd
Diabetic Nephropathy
1 trial -
albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial -
linagliptin low dose
Boehringer Ingelheim
Diabetes Mellitus, Type 2
1 trial -
metformin
BRIGHT MINDS BIOSCIENCES INC.
Type 2 Diabetes
1 trial -
metformin
Takeda
Type 2 Diabetes
1 trial -
mipomersen
IONIS PHARMACEUTICALS INC
Metabolic Diseases
1 trial -
non-preserved sterile liquid formulation
Lacuna Pharma Pty Ltd
Type 2 diabetes and Obesity
1 trial -
rencofilstat, 75 mg
Hepion Pharmaceuticals
NASH With Fibrosis
1 trial -
saxagliptin
KYOWA KIRIN AUSTRALIA PTY LTD
Diabetes, Type 2
1 trial -
tauroursodeoxycholic acid (TUDCA)
The First People's Hospital of Lianyungang
Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development
1 trial
Frequently asked questions
How many metabolic & obesity Phase II programs exist?
210 programs match both the therapeutic area and stage filters in our published index.